Clinical Trial

Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated November 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
ANRS 0146s NovaaTen study aims to determine the vaccine responses in the participants of the ANRS EP46 Novaa trial 10 years after a primary anti-yellow fever vaccination
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05450770
Lead Sponsor ANRS, Emerging Infectious Diseases
Collaborators: Saint-Louis Hospital, Paris, France, Bichat Hospital, Hôpital Cochin
Conditions HIV Infections, Yellow Fever
Enrollment 60 participants
Start Date 2024-11-01
Primary Completion 2024-11-01 (estimated)
Study Completion 2024-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-30